Title: Pharmacological Approaches for Treatment-resistant Bipolar Disorder
year: 2015
Journal: Current Neuropharmacology
Volume: 13
Issue: 5
Pages: 592-604
ISSN: 1570-159X
DOI: 10.2174/1570159X13666150630171954
Abstract: Bipolar disorder is prevalent, with high risks of disability, substance abuse and premature mortality. Treatment responses typically are incomplete, especially for depressive components, so that many cases can be considered "treatment resistant." We reviewed reports on experimental treatments for such patients: there is a striking paucity of such research, mainly involving small incompletely controlled trials of add-on treatment, and findings remain preliminary. Encouraging results have been reported by adding aripiprazole, bupropion, clozapine, ketamine, memantine, pramipexole, pregabalin, and perhaps tri-iodothyronine in resistant manic or depressive phases. The urgency of incomplete responses in such a severe illness underscores the need for more systematic, simpler, and better controlled studies in more homogeneous samples of patients.;Bipolar disorder is prevalent, with high risks of disability, substance abuse and premature mortality. Treatment responses typically are incomplete, especially for depressive components, so that many cases can be considered "treatment resistant." We reviewed reports on experimental treatments for such patients: there is a striking paucity of such research, mainly involving small incompletely controlled trials of add-on treatment, and findings remain preliminary. Encouraging results have been reported by adding aripiprazole, bupropion, clozapine, ketamine, memantine, pramipexole, pregabalin, and perhaps tri-iodothyronine in resistant manic or depressive phases. The urgency of incomplete responses in such a severe illness underscores the need for more systematic, simpler, and better controlled studies in more homogeneous samples of patients.;
Notes: http://www.syndetics.com/index.aspx?isbn=/sc.gif&issn=1570-159X&client=nusing
http://www.syndetics.com/index.aspx?isbn=/mc.gif&issn=1570-159X&client=nusing
http://www.syndetics.com/index.aspx?isbn=/lc.gif&issn=1570-159X&client=nusing
U6 - ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info:sid/summon.serialssolutions.com&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological+Approaches+for+Treatment-resistant+Bipolar+Disorder&rft.jtitle=Current+neuropharmacology&rft.au=Hui+Poon%2C+Shi&rft.au=Sim%2C+Kang&rft.au=Baldessarini%2C+Ross+J&rft.date=2015&rft.eissn=1875-6190&rft.volume=13&rft.issue=5&rft.spage=592&rft_id=info:pmid/26467409&rft.externalDocID=26467409&paramdict=en-US U7 - Journal Article
URL: http://nus.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw3V27btswFCXaTC3QoO8mTQFOWRwFkkhK4tChDZIWzRLADlBkIUiRgo3WihA7MDzk33v5ECUH7Q90tUw9eI6oe0necxAi-WmaPBoTiLTrb5kyRHMIok1NS9YYDXyjqlI1de5v-fSGnF-Sm8H5cPjtfwD-ahCj9gAE1XDjlBcms35neQKJtg0e2_Xk66KzGW6U4hxHrL2AkxO-7IZzbwdCLCZXt37xfjpfxCkbb9N8KcOn0c2W_tbWccUuGvld3TDK_hjPO_iay1PjR0lIciDn9D6fcRglI7qw0ZjIvNld7OxuCb0NcVhR0pQPn6G4OTAesuLnS72o159Nm1xPrU4AKair0fsWk2pW5dZIsW_0HL1Q0ClzuQwRxE68sZM5uAhi9hLth9Aff_GQvUJPTPsaHQe4tid4NpTCrU7wMR4BuX2Dzh7higdcMeCK_4IrDrjiHte36PrifHb2PQkOGImCB6OJlf7RMqeVVmVlvQC4Ksoma1KidN5I2lCZspoxWatSmdRAPFZqzmoDfyecMvIO7bW3rfmAMM100WhVSQavGytqxStumrymRlNe1vQAPex2nOi83Ikr_BKbzUYAz8wvuXL-TAJeCxEM3oStqrCe0N28E479IrBfWLqIjJWQaTL-U3iqiIwIRxPBhKOIAIocoLzHKV4ZElSbMbsT2PYZgWTbSmISq_LEGdz0e49obNLz4PCfRz6iZ5bOfhrtCO2t7-7NJ_S0vV_9ARb_hwE
URI: https://open-access.imh.com.sg/handle/123456789/4808
Appears in Collections:2015

Files in This Item:
There are no files associated with this item.



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.